Trademarkia Logo

Canada

C$
VECTURA
REGISTERED

on 22 Apr 2020

Last Applicant/ Owned by

VECTURA LIMITED

1 Prospect WestChippenham, Wiltshire SN14 6FH

GB

Serial Number

1843398 filed on 19th Jun 2017

Registration Number

TMA1077164 registered on 22nd Apr 2020

Registration expiry Date

22nd Apr 2030

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

CA

H3B1R1

VECTURA

Trademark usage description

pharmaceutical preparations for the treatment of diseases and conditions of the respiratory system none of the aforesaid wares are for use in the vete Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diseases and conditions of the respiratory system none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for the alleviation and prevention of pain none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; inhalers filled with powders for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations, namely, powders for asthma inhalers none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation and prevention of pain, for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for oral ingestion for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for topical administration for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of erectile dysfunction none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of chronic obstructive pulmonary disease none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of premature ejaculation none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of cystic fibrosis none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of female sexual dysfunction none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of migraines none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of asthma, none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions.


Classification kind code

11

Mark Details


Serial Number

1843398

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 4th Dec 2019
Advertised
Submitted for opposition 26
on 16th Oct 2019
Approved
Submitted for opposition 27
on 16th Oct 2019
Approval Notice Sent
Submitted for opposition 15
on 21st Jan 2019
Correspondence Created
Submitted for opposition 12
on 26th Apr 2018
Extension of Time
Submitted for opposition 22
on 11th Oct 2017
Search Recorded
Submitted for opposition 20
on 11th Oct 2017
Examiner's First Report
Submitted for opposition 31
on 27th Jun 2017
Formalized
Submitted for opposition 1
on 20th Jun 2017
Created
Submitted for opposition 30
on 19th Jun 2017
Filed